Diabetic Medicines

As per available reports about 1668 journals, 74 Conferences, are presently dedicated exclusively to Diabetic Medicines and about 7027 articles are being published on the current trends in Diabetic Medicines. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Diabetic Medicine are being carried out. As reported in the above articles, Diabetic Medicines is the study of Drugs used in diabetes treat diabetes mellitus by lowering glucose levels in the blood. With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents. There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors.
 

The Journal of Diabetes & Metabolism is a peer reviewed open access Journal publishing the articles on Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Gestational Diabetes, Cardio Vascular Research, Endocrinology, Diabetes Therapy, Diabetic Drugs, Genetics of Diabetes etc., Articles published in this journal are subjected to rigorous peer review and revision process before being accepted for publication, to maintain quality and the standards set for academic journals. This Journal ensures the barrier-free distribution of its content through online free access and thus helps in improving the citations for authors and attaining a good impact factor.

OMICS International – a pioneer in organizing international conferences 5th World Congress on Diabetes & Metabolism November 03-05, 2014 Las Vegas, USA. With the success of conference on various clinical, medical and management science, OMICS Group for the fifth time is going to organize a conference on 5th World Congress on Diabetes & Metabolism to be held on November 03-05, 2014 Las Vegas, USA. The previous four Diabetes congresses were held at Santa Clara-USA, Philadelphia-USA, Hyderabad-India and Chicago-USA had achieved a grand success. Now it is the time for the 5th World Congress on Diabetes to address new challenges and emerging issues in Diabetes. Diabetes is the premier event that brings together a unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build a world Diabetes community.